Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy

INTRODUCTION: In 2008, the Food and Drugs Administration required manufacturers of TNFα antagonists to strengthen their warnings about the risk of serious fungal infections in patients with rheumatoid arthritis (RA). Sinus aspergilloma occurs occasionally in RA patients and can progress to invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Leboime, Ariane, Berthelot, Jean-Marie, Allanore, Yannick, Khalil-Kallouche, Lama, Herman, Philippe, Orcel, Philippe, Lioté, Frédéric
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003503/
https://www.ncbi.nlm.nih.gov/pubmed/19886992
http://dx.doi.org/10.1186/ar2849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003503/
https://www.ncbi.nlm.nih.gov/pubmed/19886992
http://dx.doi.org/10.1186/ar2849

Ejemplares similares